Takeda to Present Data During 60th American Society of Hematology Annual Meeting on Wide Array of Treatment Needs for Blood Cancers
TAKEDA PHARMA (TKPYY)
NASDAQ:AMEX Investor Relations:
takeda.com/investors
Company Research
Source: Business Wire
– Results from Phase 3 Studies Including TOURMALINE-MM3 Trial of NINLARO™ (ixazomib) as Post- Autologous Stem Cell Transplant Maintenance Therapy and ECHELON-2 Trial of ADCETRIS® (brentuximab vedotin) in Frontline CD30-Positive Peripheral T-Cell Lymphoma Featured in Oral Sessions – – Expansive Collection of 18 Abstracts Highlight Takeda’s Hematology-Oncology Portfolio in Multiple Myeloma, Lymphoma, Chronic Myeloid Leukemia and Myelodysplastic Syndromes – CAMBRIDGE, Mass. & OSAKA, Japan--(BUSINESS WIRE)-- Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that it will present a total of 18 company-sponsored abstracts at the 60th American Society of Hematology (ASH) Annual Meeting taking place in San Diego from December 1 to 4, 2018. Takeda’s presentations will feature new data from clinical studies across the company’s hematology portfolio. Notably, Takeda will present data fro
Show less
Read more
Impact Snapshot
Event Time:
TKPYY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TKPYY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TKPYY alerts
High impacting TAKEDA PHARMA news events
Weekly update
A roundup of the hottest topics